Literature DB >> 12573666

Gene transfer into rabbit keratocytes using AAV and lipid-mediated plasmid DNA vectors with a lamellar flap for stromal access.

Rajiv R Mohan1, Gregory S Schultz, Jong Wook Hong, Rahul R Mohan, Steven E Wilson.   

Abstract

Development of gene transfer methods that can precisely deliver therapeutic genes to the localized or targeted tissue(s) would be highly beneficial in developing new gene therapy approaches and may also extend animal models for studying in vivo gene function and regulation at molecular levels in the selected tissues. We investigated lipid- and AAV-mediated gene transfer in rabbit cornea using a lamellar flap-technique. The goals of this study were to (1) analyze methods for in situ gene transfer into keratocytes, (2) identify efficient and suitable vectors for gene transfer into keratocytes, and (3) characterize times of first detectable expression, localization and duration of transgene expression in keratocytes with different vectors. A lamellar flap was produced in the rabbit cornea with a microkeratome. Recombinant adeno-associated viral vector (rAAV) expressing either beta-galactosidase (rAAV-beta-gal) or chloramphenicol acetyltransferase (rAAV-CAT) reporter genes, or plasmid-cationic lipid complexes expressing CAT (pMP6-CAT) or beta-galactosidase (pTR-beta-gal) were applied beneath the lamellar flap for two minutes. The flap was repositioned and eyelids sutured overnight. Corneas were removed at 4hr, 12hr, 36hr, 3 days, 7 days, or 10 days after application and either fixed in 2% formaldehyde, cryosectioned and stained for beta-galactosidase activity or homogenized and measured for CAT levels by ELISA. Corneas infected with rAAV-beta-gal vector showed positive beta-gal staining in the center and periphery of the flap interface in whole corneas and corneal beds at 3, 7, and 10 days, but not at earlier time points. Corneas treated with pTR-beta-gal plasmid vector showed positive beta-gal expression at the interface at 4, 12 and 36hr, but not at 3 or 7 days. The posterior surface of the lamellar interface where the vector was applied showed more expression than the overlying anterior surface with both plasmid and viral vectors. The level of gene expression was less with plasmid vector than viral vector monitored using beta-gal staining. CAT-ELISA confirmed expression of the CAT reporter gene with either the plasmid or rAAV vector. These results demonstrate that foreign genes can be introduced into keratocytes with plasmid or viral vectors using a lamellar flap to gain access to the stroma. The expression profile of the reporter genes depended on the vector. Transfection of keratocytes with plasmid vectors produced rapid expression of the reporter genes, but for a short duration. Reporter gene expression following transduction by rAAV vector was delayed several days, but was at higher levels and for a longer duration. This is the first report to demonstrate selective gene transfer into keratocytes and would be highly useful in studying function and regulation of genes in vivo and may eventually furnish a tool for the treatment of corneal dystrophies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12573666     DOI: 10.1016/s0014-4835(02)00275-0

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  23 in total

1.  AAV serotype influences gene transfer in corneal stroma in vivo.

Authors:  Ajay Sharma; Jonathan C K Tovey; Arkasubhra Ghosh; Rajiv R Mohan
Journal:  Exp Eye Res       Date:  2010-06-30       Impact factor: 3.467

2.  Transduction, tropism, and biodistribution of AAV vectors in the lacrimal gland.

Authors:  Eduardo M Rocha; Giovanni Di Pasquale; Paola Perez Riveros; Kathrina Quinn; Beverly Handelman; John A Chiorini
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-12-20       Impact factor: 4.799

Review 3.  Corneal gene therapy: basic science and translational perspective.

Authors:  Rajiv R Mohan; Jason T Rodier; Ajay Sharma
Journal:  Ocul Surf       Date:  2013-02-13       Impact factor: 5.033

4.  Significant inhibition of corneal scarring in vivo with tissue-selective, targeted AAV5 decorin gene therapy.

Authors:  Rajiv R Mohan; Ashish Tandon; Ajay Sharma; John W Cowden; Jonathan C K Tovey
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-01       Impact factor: 4.799

5.  Gene delivery in the equine cornea: a novel therapeutic strategy.

Authors:  Dylan G Buss; Elizabeth Giuliano; Ajay Sharma; Rajiv R Mohan
Journal:  Vet Ophthalmol       Date:  2010-09       Impact factor: 1.644

Review 6.  Progress in corneal wound healing.

Authors:  Alexander V Ljubimov; Mehrnoosh Saghizadeh
Journal:  Prog Retin Eye Res       Date:  2015-07-18       Impact factor: 21.198

7.  Multi-gene targeted antiangiogenic therapies for experimental corneal neovascularization.

Authors:  Peng Chen; Hongmei Yin; Yao Wang; Jing Mi; Wenxiao He; Lixin Xie; Yiqiang Wang
Journal:  Mol Vis       Date:  2010-02-27       Impact factor: 2.367

8.  Viral capsid is a pathogen-associated molecular pattern in adenovirus keratitis.

Authors:  Ashish V Chintakuntlawar; Xiaohong Zhou; Jaya Rajaiya; James Chodosh
Journal:  PLoS Pathog       Date:  2010-04-15       Impact factor: 6.823

9.  Transduction efficiency of AAV 2/6, 2/8 and 2/9 vectors for delivering genes in human corneal fibroblasts.

Authors:  Ajay Sharma; Arkasubhra Ghosh; Eric T Hansen; Jason M Newman; Rajiv R Mohan
Journal:  Brain Res Bull       Date:  2009-07-16       Impact factor: 4.077

Review 10.  Gene therapy in corneal transplantation.

Authors:  Yureeda Qazi; Pedram Hamrah
Journal:  Semin Ophthalmol       Date:  2013 Sep-Nov       Impact factor: 1.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.